Evidence map›Paper›PMID 42430225›Full record

ArticleNano letters2026

Plasmon Engineering in Intercalated 2H-TaS

Luigi Camerano, Laura Martella, Lorenzo Battaglia, Federico Giannessi, Filippo Camilli, Luca Lozzi, Polina M Sheverdyaeva, Paolo Moras, Luca Ottaviano, Gianni Profeta and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nano letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Luigi CameranoDepartment of Physical and Chemical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.ORCID 0009-0000-9454-1649
Laura MartellaDepartment of Physical and Chemical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.
Lorenzo BattagliaDepartment of Physical and Chemical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.
Federico GiannessiDepartment of Physical and Chemical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.
Filippo CamilliDepartment of Physical and Chemical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.
Luca LozziDepartment of Physical and Chemical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.
Polina M SheverdyaevaCNR-Istituto di Struttura della Materia (CNR-ISM), Strada Statale 14, km 163.5, 34149 Trieste, Italy.ORCID 0000-0002-4231-1638
Paolo MorasCNR-Istituto di Struttura della Materia (CNR-ISM), Strada Statale 14, km 163.5, 34149 Trieste, Italy.
Luca OttavianoDepartment of Physical and Chemical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.
Gianni ProfetaDepartment of Physical and Chemical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.ORCID 0000-0002-0535-7573
Federico BistiDepartment of Physical and Chemical Sciences, University of L'Aquila, Via Vetoio, 67100 L'Aquila, Italy.ORCID 0000-0002-7562-5182

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plasmons in low-dimensional materials provide a powerful platform for nanoscale control of light-matter interactions, yet strategies to tailor their coherence and dissipation remain limited. Here, we demonstrate that transition-metal intercalation offers a fundamentally distinct route to engineer plasmonic response in layered materials. By combining high-resolution core-level photoemission spectroscopy with first-principles calculations, we show that Fe and Co intercalation in 2H-TaS

Indexed as

core-levelselectron energy lossintercalationphotoemissionplasmonsTMD

Identifiers

PMID42430225
PMCPMC13397885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.